منابع مشابه
[Retinal toxicity following chloroquine therapy].
CASE REPORT Two cases of bilateral ocular toxicity following chloroquine therapy in two women with systemic lupus erythematosus are presented. DISCUSSION Retinal toxicity due to chloroquine is an uncommon iatrogenic disease. It is dose-dependent. New cases are still being described despite the application of ophthalmic screening techniques.
متن کاملRetinal toxicity in long term hydroxychloroquine treatment.
OBJECTIVE To report clinical experience from patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) who were receiving recommended doses of hydroxychloroquine for more than six years, and were monitored for evidence of hydroxychloroquine related retinopathy every six months. METHODS A prospective (and continuing) evaluation was made of the potential retinal toxicity of...
متن کاملTherapeutic photobiomodulation for methanol-induced retinal toxicity.
Methanol intoxication produces toxic injury to the retina and optic nerve, resulting in blindness. The toxic metabolite in methanol intoxication is formic acid, a mitochondrial toxin known to inhibit the essential mitochondrial enzyme, cytochrome oxidase. Photobiomodulation by red to near-IR radiation has been demonstrated to enhance mitochondrial activity and promote cell survival in vitro by ...
متن کاملComparative evaluation of the toxicity of Amikacin and Cefepime on rat’s kidney and liver
Aminoglycosides are known to cause oxidative stress related toxicities and tissue injuries and Cefepime is cephalosporin class of antibiotics having potential of free radical scavenging properties. The objective of present study was to evaluate effect of Amikacin on various antioxidant enzymes (Superoxide dismutase Catalase and Glutathione Reductase) along with malonaldialdehyde levels and extr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Ophthalmology
سال: 1999
ISSN: 0007-1161
DOI: 10.1136/bjo.83.10.1194f